Abstract:
The present invention relates to antibodies binding to native proBNP, a method for specific detection of native proBNP, a method of correlating the level of native proBNP to the diagnosis of heart failure, a kit for detection of native proBNP and to a hybridoma cell line producing an antibody to native proBNP.
Abstract:
The present invention relates to antibodies specifically binding to native proBNP, a method for specific detection of native proBNP, a method of correlating the level of native proBNP to the diagnosis of heart failure, a kit for detection of native proBNP and to a hybridoma cell line producing an antibody to native proBNP.
Abstract:
The invention relates to a method of identifying N-terminal proBNP in a sample with at least two antibodies that detect different epitopes of the N-terminal proBNP. The method is used to differentiate or classify samples of healthy individuals and samples of patients of NYHA classes I to I. The invention further relates to recombinant N-terminal proBNP, its use as standard in a method of identifying N-terminal proBNP, to antibodies that detect recombinant N-terminal proBNP and to their production.
Abstract:
In a process for the immunological detection of heart muscle necroses a blood sample is allowed to react with at least one antibody which recognizes the N-terminal peptide of cardiac troponine I and can be obtained by immunization with an immunogene containing the amino acid sequence SEQ ID NO 1 or partial sequences thereof at least 6 amino acids in length, the polyclonal or monoclonal antibody being extracted by known methods from the serum or from the immortalized and cloned spleen cells of the immunized animals. The complex which then forms is detected in the appropriate way.